pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
esketamine
Treatment Resistant Depression
Glutamate [NMDA] receptor
Bioron Pharma
2 catalysts
Phase 2
teverelix
teverelix [INN]
Prostate Cancer
Antev Ltd
2 catalysts
Phase 2
BW-20805
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Shanghai Argo Pharmaceutical Co Ltd
1 catalysts
← prev
page 1 of 53
next →
131
Pain89
Neurology1
Phase 2
LTG-001
Post-Operative Pain
Latigo Biotherapeutics Inc
1 catalysts
Phase 2
ONO-4578
Metastatic Colorectal Cancer
Bristol-Myers Squibb Co
1 catalysts
Phase 2
QA-102
Dry (Atrophic) Macular Degeneration
Guangzhou Yinming Biomedical Technology Co Ltd
1 catalysts
Phase 2
bofanglutide
Obesity
Gan & Lee Pharmaceuticals Co Ltd
1 catalysts
Phase 2
brentuximab vedotin
Adcetris (brentuximab vedotin)
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
TubulinTumor necrosis factor receptor superfamily member 8
$PFEPFIZER INC
1 catalysts
Phase 2
cadonilimab
Hepatocellular Carcinoma
Programmed cell death protein 1Cytotoxic T-lymphocyte protein 4
Akeso Inc
1 catalysts
Phase 2
clofutriben
Cushing's Syndrome
Sparrow Pharmaceuticals Inc
1 catalysts
Phase 2
dostarlimab
Jemperli (dostarlimab-gxly)
Rectal Cancer
Programmed cell death protein 1
$GSKGSK plc
1 catalysts
Phase 2
emavusertib hydrochloride
Chronic Lymphocytic Leukemia (CLL)
$CRISCURIS INC
1 catalysts
Phase 2
navlimetostat
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
1 catalysts
Phase 2
pirenzepine
Diabetic Peripheral Neuropathy
Muscarinic acetylcholine receptor M1
WinSanTor Inc
1 catalysts
Phase 2
samuraciclib
samuraciclib [INN]
Breast Cancer
Carrick Therapeutics Ltd
1 catalysts
Phase 2
siplizumab
Vicalex (siplizumab)
Transplant Rejection
T-cell surface antigen CD2
ITB-Med AB
1 catalysts
Phase 2
soficabtagene geleucel
soficabtagene geleucel [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Wugen Inc
1 catalysts
Phase 2
toripalimab
Loqtorzi (toripalimab-tpzi)
Esophageal Squamous Cell Carcinoma (ESCC)
Programmed cell death protein 1
$CHRSCoherus Oncology, Inc.
1 catalysts
Phase 2
tulisokibart
Systemic Sclerosis (Scleroderma)
$MRKMerck & Co., Inc.
1 catalysts
Phase 2
ubidecarenone
ubidecarenone [INN]
Metastatic Adenocarcinoma of The Pancreas
BPGbio Inc
1 catalysts
Phase 2
(MET-233i + MET-097i)
Obesity
Metsera Inc
0 catalysts
Phase 2
(acetaminophen + pregabalin)
Dental Pain (Toothache/Tooth Pain)
Nevakar Injectables Inc
0 catalysts
Phase 2
(atigotatug + nivolumab)
(atigotatug [INN] + nivolumab)
Small-Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 2
(betovumeline + fesoterodine)
(betovumeline + fesoterodine [INN])
Alzheimer's Disease
$MPLTMapLight Therapeutics, Inc.
0 catalysts
Phase 2
(bremelanotide + tadalafil)
Erectile Dysfunction
$PTNTPALATIN TECHNOLOGIES INC
0 catalysts
Phase 2
(buspirone hydrochloride + testosterone)
lybrido ((buspirone hydrochloride + testosterone))
Female Hypoactive Sexual Desire Disorder
Arletta Pharma Solutions BV
0 catalysts
Phase 2
(cannabidiol + esketamine)
Major Depressive Disorder
Bioron Pharma
0 catalysts
Phase 2
(cefepime + tazobactam sodium)
Pyelonephritis
Wockhardt Ltd
0 catalysts
Phase 2
(celecoxib + ciprofloxacin)
Amyotrophic Lateral Sclerosis
$NRSNNeuroSense Therapeutics Ltd.
0 catalysts
Phase 2
(celecoxib + famciclovir)
Fibromyalgia (Fibromyalgia Syndrome)
$DWTXDogwood Therapeutics, Inc.
0 catalysts